272 related articles for article (PubMed ID: 22171124)
1. Proteome-based biomarkers in pancreatic cancer.
Sun C; Rosendahl AH; Ansari D; Andersson R
World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
[TBL] [Abstract][Full Text] [Related]
2. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
[TBL] [Abstract][Full Text] [Related]
3. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: diagnosis and treatments.
Li HY; Cui ZM; Chen J; Guo XZ; Li YY
Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of bodily fluids in pancreatic cancer.
Pan S; Brentnall TA; Chen R
Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
[TBL] [Abstract][Full Text] [Related]
7. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
[TBL] [Abstract][Full Text] [Related]
8. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
Guo J; Xie K; Zheng S
Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
[TBL] [Abstract][Full Text] [Related]
9. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.
Ger M; Kaupinis A; Petrulionis M; Kurlinkus B; Cicenas J; Sileikis A; Valius M; Strupas K
Anticancer Res; 2018 Oct; 38(10):5759-5765. PubMed ID: 30275197
[TBL] [Abstract][Full Text] [Related]
11. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
12. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
Farina A
Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive proteomic analysis of human pancreatic juice.
Grønborg M; Bunkenborg J; Kristiansen TZ; Jensen ON; Yeo CJ; Hruban RH; Maitra A; Goggins MG; Pandey A
J Proteome Res; 2004; 3(5):1042-55. PubMed ID: 15473694
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
15. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207
[TBL] [Abstract][Full Text] [Related]
16. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
17. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
19. Strategies for discovering novel pancreatic cancer biomarkers.
Chan A; Diamandis EP; Blasutig IM
J Proteomics; 2013 Apr; 81():126-34. PubMed ID: 23026552
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of pancreatic cancer using serum proteomic profiling.
Bhattacharyya S; Siegel ER; Petersen GM; Chari ST; Suva LJ; Haun RS
Neoplasia; 2004; 6(5):674-86. PubMed ID: 15548376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]